ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $343,000 | +36.1% | 18,132 | -15.4% | 0.00% | – |
| Q2 2019 | $252,000 | +20.6% | 21,428 | +39.7% | 0.00% | – |
| Q1 2019 | $209,000 | +23.7% | 15,339 | -7.3% | 0.00% | – |
| Q4 2018 | $169,000 | -37.2% | 16,546 | +2.6% | 0.00% | – |
| Q3 2018 | $269,000 | +5.5% | 16,123 | -0.0% | 0.00% | – |
| Q2 2018 | $255,000 | +27.5% | 16,131 | +2.6% | 0.00% | – |
| Q1 2018 | $200,000 | -52.6% | 15,717 | -57.4% | 0.00% | – |
| Q4 2017 | $422,000 | +76.6% | 36,881 | +89.1% | 0.00% | – |
| Q3 2017 | $239,000 | +408.5% | 19,505 | +370.8% | 0.00% | – |
| Q2 2017 | $47,000 | -59.8% | 4,143 | -26.0% | 0.00% | – |
| Q1 2017 | $117,000 | +2825.0% | 5,602 | +3047.2% | 0.00% | – |
| Q4 2016 | $4,000 | -33.3% | 178 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +50.0% | 178 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -50.0% | 178 | -45.1% | 0.00% | – |
| Q1 2016 | $8,000 | +14.3% | 324 | +54.3% | 0.00% | – |
| Q4 2015 | $7,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |